| |
 |
|
Class Information
Number: 514/2
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Peptide containing (e.g., protein, peptones, fibrinogen, etc.) doai
Description: Subject matter which contains a protein or its reaction product, e.g., peptides, peptones, fibrinogen, etc., wherein the protein molecule is not degraded to the constituent amino-acids.
Sub-classes under this class:
| Class Number |
Class Name |
Patents |
| 514/14 |
12 to 15 peptide repeating units in known peptide chain |
1,115 |
| 514/13 |
16 to 24 peptide repeating units in known peptide chain |
1,152 |
| 514/19 |
2 peptide repeating units in known peptide chain |
1,319 |
| 514/12 |
25 or more peptide repeating units in known peptide chain structure |
5,597 |
| 514/18 |
3 or 4 peptide repeating units in known peptide chain |
1,596 |
| 514/17 |
5 or 6 peptide repeating units in known peptide chain |
1,071 |
| 514/16 |
7 or 8 peptide repeating units in known peptide chain |
1,047 |
| 514/15 |
9 to 11 peptide repeating units in known peptide chain |
1,375 |
| 514/9 |
Cyclopeptides |
698 |
| 514/8 |
Glycoprotein (carbohydrate containing) |
2,033 |
| 514/6 |
Heavy metal containing (e.g., hemoglobin, etc.) |
451 |
| 514/3 |
Insulin or derivative |
608 |
| 514/5 |
Iodine containing |
42 |
| 514/7 |
Phosphorus containing |
196 |
| 514/21 |
Produced by or extracted from animal tissue |
2,378 |
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7514398 |
Growth factor complex |
Apr. 7, 2009 |
| 7514397 |
Methods for inhibition of membrane-fusion-associated events, including Hepatitis B virus transmission |
Apr. 7, 2009 |
| 7514101 |
Artificial bait based on a peptide attractant found in horseshoe crab eggs |
Apr. 7, 2009 |
| 7514092 |
Compositions and methods of their use for improving the condition and appearance of skin |
Apr. 7, 2009 |
| 7514082 |
Anti-viral VSF protein and hybridoma producing the same |
Apr. 7, 2009 |
| 7514077 |
Methods of antagonizing signal transduction in dorsal root ganglion cells with IL-31 antagonists |
Apr. 7, 2009 |
| 7514076 |
Antitumor agents |
Apr. 7, 2009 |
| 7514072 |
Method for the treatment of cerebral ischaemia and use of erythropoietin or erythropoietin derivatives for the treatment of cerebral ischaemia |
Apr. 7, 2009 |
| 7511095 |
Thioester-terminated water soluble polymers and method of modifying the N-terminus of a polypeptide therewith |
Mar. 31, 2009 |
| 7511019 |
Method of treating coronary artery disease by administering FGF-4 |
Mar. 31, 2009 |
| 7511017 |
Methods of treatment with TNFR5 |
Mar. 31, 2009 |
| 7511012 |
Myostatin binding agents |
Mar. 31, 2009 |
| 7511011 |
Synthetic lipid mixtures for the preparation of a reconstituted surfactant |
Mar. 31, 2009 |
| 7511010 |
Pharmaceutical or cosmetic composition and use of a PKC inhibitor with an MMP inhibitor for inhibiting Langerhans' cell migration |
Mar. 31, 2009 |
| 7511009 |
Retinal pigmented epithelium derived neurotrophic factor |
Mar. 31, 2009 |
| 7510840 |
Method of inhibiting growth or survival of a cell by providing an anti-108P5H8 antibody |
Mar. 31, 2009 |
| 7510720 |
Vaccine to control equine protozoal myeloencephalitis in horses |
Mar. 31, 2009 |
| 7507745 |
Pharmaceutical compositions based on fluorenecarboxylic acid esters and soluble TNF receptor fusion proteins |
Mar. 24, 2009 |
| 7507716 |
Method for treating pain with prolactin antagonists |
Mar. 24, 2009 |
| 7507710 |
Anti-amyloid immunogenic compositions, methods and uses |
Mar. 24, 2009 |
| 7507709 |
Synergistic effects of OP/BMP morphogens and GDNF/NGF neurotrophic factors |
Mar. 24, 2009 |
| 7507708 |
Antitumoral compounds |
Mar. 24, 2009 |
| 7507707 |
Methods of inducing ovulation using a non-polypeptide camp level modulator |
Mar. 24, 2009 |
| 7507706 |
Cytokine receptor chain |
Mar. 24, 2009 |
| 7507705 |
Methods for the modulation of neovascularization and/or the growth of collateral arteries and/or other arteries from preexisting arteriolar connections |
Mar. 24, 2009 |
| 7507419 |
Topically applied Clostridium botulinum toxin compositions and treatment methods |
Mar. 24, 2009 |
| 7507413 |
Albumin fusion proteins |
Mar. 24, 2009 |
| 7504379 |
Protection of cardiac myocardium |
Mar. 17, 2009 |
| 7504375 |
Antimicrobial polypeptides |
Mar. 17, 2009 |
| 7504374 |
Method for inducing deposition and maturation of bone comprising a co-therapeutic regimen of LMP-1 and BMP-2 |
Mar. 17, 2009 |
| 7504110 |
Protein-based Streptococcus pneumoniae vaccines |
Mar. 17, 2009 |
| 7504106 |
Method and composition for treatment of renal failure with antibodies and their equivalents as partial or complete replacement for dialysis |
Mar. 17, 2009 |
| 7504096 |
Methods for in vitro fertilization |
Mar. 17, 2009 |
| 7504086 |
Structure and method for releasing substance therefrom |
Mar. 17, 2009 |
| 7501396 |
Methods for treating joint pain using poly-gamma-glutamic acid |
Mar. 10, 2009 |
| 7501395 |
Method of screening for antianxiety drugs |
Mar. 10, 2009 |
| 7501392 |
Method of treatment of viral hepatitis C with interferon alpha 5 |
Mar. 10, 2009 |
| 7501391 |
Treatment of transplant survival |
Mar. 10, 2009 |
| 7501134 |
Microparticles with adsorbed polypeptide-containing molecules |
Mar. 10, 2009 |
| 7501132 |
Multiple antigenic peptides immunogenic against Streptococcus pneumonia |
Mar. 10, 2009 |
| 7501125 |
Vivo CTL elicitation by heat shock protein fusion proteins maps to a discrete domain and is CD4+ T cell-independent |
Mar. 10, 2009 |
| 7498310 |
Cosmetic or dermatological preparations comprising oligopeptides for lightening the skin of age marks and/or for preventing tanning of the skin, in particular tanning of the skin caused by UV |
Mar. 3, 2009 |
| 7498306 |
Peptides binding to the phosphatase 2A protein |
Mar. 3, 2009 |
| 7498299 |
Procollagen (III) propeptides and related substances for treating fibrotic diseases |
Mar. 3, 2009 |
| 7498298 |
Monomethylvaline compounds capable of conjugation to ligands |
Mar. 3, 2009 |
| 7498297 |
Medicinal uses of mu-opioid receptor agonists |
Mar. 3, 2009 |
| 7498035 |
Compounds of hydrophilic polymer-polycarboxyl oligopeptide and medicines, medical composite comprising above compound and use of above compound in medicines |
Mar. 3, 2009 |
| 7498025 |
Targeted bifunctional molecules and therapies based thereon |
Mar. 3, 2009 |
| 7498021 |
Dental products comprising bone growth enhancing peptide |
Mar. 3, 2009 |
| 7495030 |
(5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents |
Feb. 24, 2009 |
|
|
|
